文献速递肝病消化内镜

内镜介导的胆道流体动力学注射在猪肝实现临床相关水平的基因递送

Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver.
PubMed 文献 · Gastrointest Endosc · 2021-06-29

本研究探索经ERCP向猪胆道系统行流体动力学注射质粒DNA(pDNA)以实现肝基因递送,以人凝血因子IX(hFIX)为模型基因。胆道流体动力学注射耐受良好,无生命体征、肝酶、血液学或组织学显著变化,未检测到脱靶递送。5.5 mg pDNA注射后50.19%肝组织hFIX染色阳性,转染效率显著高于小鼠血管流体动力学注射(32.7%-51.9% vs 18.9%,P < .0001)。

要点

  • 经ERCP胆道流体动力学注射pDNA在猪肝耐受良好,无显著肝酶及组织学异常。
  • 5.5 mg pDNA注射后50.19%肝组织hFIX染色阳性,所有肝叶每个肝小叶均见表达。
  • 猪胆道流体动力学注射转染效率显著高于小鼠血管流体动力学注射(P < .0001)。

核心结论

  • 经ERCP胆道流体动力学注射可在人尺寸大动物猪肝实现高于AAV的肝细胞转染效率,且成本更低,可能成为人肝病基因治疗平台。

研究设计与样本

  • 在猪肝中经ERCP和动力注射器提供流体动力,经胆道系统递送pDNA,以hFIX为模型基因治疗。

主要发现

  • 胆道流体动力学注射耐受良好,生命体征、肝酶、血液学及组织学无显著变化。
  • PCR未检测到pDNA脱靶递送至其他器官。
  • 5.5 mg pDNA注射后免疫组化显示50.19%肝组织hFIX染色阳性,所有肝叶每个肝小叶均见hFIX表达。
  • hFIX阳性肝细胞集中于中央静脉周围,向外辐射分布于全部3个代谢带。
  • 猪胆道流体动力学注射在匹配每肝重pDNA剂量下转染效率显著高于小鼠血管流体动力学注射(32.7%-51.9% vs 18.9%,P < .0001)。

关键数值与推荐

  • 5.5 mg pDNA胆道流体动力学注射后50.19%肝组织hFIX染色阳性。
  • 猪胆道流体动力学注射转染效率32.7%-51.9%,小鼠血管流体动力学注射18.9%,P < .0001。

临床怎么用

  • 该技术经ERCP即可实施,在猪模型中耐受良好且转染效率高,支持向人肝病基因治疗临床转化探索。

局限性

  • 研究为猪模型,样本量未在摘要中报告,尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Gene therapy could provide curative therapies to many inherited monogenic liver diseases. Clinical trials have largely focused on adeno-associated viruses (AAVs) for liver gene delivery. These vectors, however, are limited by small packaging size, capsid immune responses, and inability to redose. As an alternative, nonviral, hydrodynamic injection through vascular routes can successfully deliver plasmid DNA (pDNA) into mouse liver but has achieved limited success in large animal models. METHODS: We explored hydrodynamic delivery of pDNA through the biliary system into the liver of pigs using ERCP and a power injector to supply hydrodynamic force. Human factor IX (hFIX), deficient in hemophilia B, was used as a model gene therapy. RESULTS: Biliary hydrodynamic injection was well tolerated without significant changes in vital signs, liver enzymes, hematology, or histology. No off-target pDNA delivery to other organs was detected by polymerase chain reaction. Immunohistochemistry revealed that 50.19% of the liver stained positive for hFIX after hydrodynamic injection at 5.5 mg pDNA, with every hepatic lobule in all liver lobes demonstrating hFIX expression. hFIX-positive hepatocytes were concentrated around the central vein, radiating outward across all 3 metabolic zones. Biliary hydrodynamic injection in pigs resulted in significantly higher transfection efficiency than mouse vascular hydrodynamic injection at matched pDNA per liver weight dose (32.7%-51.9% vs 18.9%, P < .0001). CONCLUSIONS: Biliary hydrodynamic injection using ERCP can achieve higher transfection efficiency into hepatocytes compared with AAVs at magnitudes of less cost in a clinically relevant human-sized large animal. This technology may serve as a platform for gene therapy of human liver diseases.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Kruse RL, Huang Y, Shum T, et al. Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver. Gastrointest Endosc. 2021. PMID: 34197834. doi:10.1016/j.gie.2021.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。